Ignite Creation Date:
2024-05-05 @ 5:14 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00418938
Status:
COMPLETED
Last Update Posted:
2018-10-17
First Post:
2007-01-04
Brief Title:
SPIRITT - Second-Line Panitumumab Irinotecan Treatment Trial
Sponsor:
Amgen
Organization:
Amgen
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-11-01
Start Date Type:
ACTUAL
Primary Completion Date:
2012-05-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-04-01
Completion Date Type:
ACTUAL
First Submit Date:
2007-01-04
First Submit QC Date:
January 4 2007
Study First Post Date:
2007-01-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2014-03-28
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2010-07-20
Disp First Submit QC Date:
July 20 2010
Disp First Post Date:
2010-07-22
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2018-09-20
Last Update Post Date:
2018-10-17
Last Update Post Date Type:
ACTUAL